Molecular targets and mechanisms of Guanxinning tablet in treating atherosclerosis: Network pharmacology and molecular docking analysis

BACKGROUND: Guanxinning tablet (GXNT), a Chinese patent medicine, is composed of salvia miltiorrhiza bunge and ligusticum striatum DC, which may play the role of endothelial protection through many pathways. We aimed to explore the molecular mechanisms of GXNT against atherosclerosis (AS) through ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Niu, Chaofeng, Zhang, Peiyu, Zhang, Lijing, Lin, Dingfeng, Lai, Haixia, Xiao, Di, Liu, Yong, Zhuang, Rui, Li, Meng, Ma, Liyong, Ye, Jiaqi, Pan, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
3800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545342/
https://www.ncbi.nlm.nih.gov/pubmed/37773840
http://dx.doi.org/10.1097/MD.0000000000035106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545342/
https://www.ncbi.nlm.nih.gov/pubmed/37773840
http://dx.doi.org/10.1097/MD.0000000000035106

Ejemplares similares